Clinical Trial Detail

NCT ID NCT01493843
Title Study Evaluating the Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Genentech
Indications

lung non-small cell carcinoma

Therapies

Carboplatin

Pictilisib

Bevacizumab

Age Groups: adult

No variant requirements are available.